Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 197

1.

Prevention of damage induced by aspirin in the GI tract.

Scheiman JM.

Best Pract Res Clin Gastroenterol. 2012 Apr;26(2):153-62. doi: 10.1016/j.bpg.2012.01.005. Review.

PMID:
22542153
2.

Strategies to reduce the GI risks of antiplatelet therapy.

Scheiman JM.

Rev Cardiovasc Med. 2005;6 Suppl 4:S23-31. Review.

PMID:
17710073
3.

The risk of upper gastrointestinal bleeding in elderly users of aspirin and other non-steroidal anti-inflammatory drugs: the role of gastroprotective drugs.

Pilotto A, Franceschi M, Leandro G, Paris F, Niro V, Longo MG, D'Ambrosio LP, Andriulli A, Di Mario F.

Aging Clin Exp Res. 2003 Dec;15(6):494-9.

PMID:
14959953
4.

Poor awareness of preventing aspirin-induced gastrointestinal injury with combined protective medications.

Zhu LL, Xu LC, Chen Y, Zhou Q, Zeng S.

World J Gastroenterol. 2012 Jun 28;18(24):3167-72. doi: 10.3748/wjg.v18.i24.3167.

6.

Systematic reviews of the clinical effectiveness and cost-effectiveness of proton pump inhibitors in acute upper gastrointestinal bleeding.

Leontiadis GI, Sreedharan A, Dorward S, Barton P, Delaney B, Howden CW, Orhewere M, Gisbert J, Sharma VK, Rostom A, Moayyedi P, Forman D.

Health Technol Assess. 2007 Dec;11(51):iii-iv, 1-164. Review.

7.

Low-dose aspirin and upper gastrointestinal damage: epidemiology, prevention and treatment.

Lanas A, Scheiman J.

Curr Med Res Opin. 2007 Jan;23(1):163-73. Review.

PMID:
17257477
8.

[Risk of gastrointestinal bleeding with aspirin and platelet antiaggregants].

Nardulli G, Lanas A.

Gastroenterol Hepatol. 2009 Jan;32(1):36-43. doi: 10.1016/j.gastrohep.2008.02.001. Epub 2008 Dec 31. Review. Spanish.

PMID:
19174098
9.

Gastrointestinal bleeding associated with low-dose aspirin use: relevance and management in clinical practice.

Lanas A.

Expert Opin Drug Saf. 2011 Jan;10(1):45-54. doi: 10.1517/14740338.2010.507629. Epub 2010 Jul 20. Review.

PMID:
20645883
10.

Upper GI risks of NSAIDs and antiplatelet agents: key issues for the cardiologist.

Johnson DA.

Rev Cardiovasc Med. 2005;6 Suppl 4:S15-22. Review.

PMID:
17710072
11.

A comparison of aspirin and clopidogrel with or without proton pump inhibitors for the secondary prevention of cardiovascular events in patients at high risk for gastrointestinal bleeding.

Hsiao FY, Tsai YW, Huang WF, Wen YW, Chen PF, Chang PY, Kuo KN.

Clin Ther. 2009 Sep;31(9):2038-47. doi: 10.1016/j.clinthera.2009.09.005.

PMID:
19843493
12.

New look at antiplatelet agent-related peptic ulcer: an update of prevention and treatment.

Hsu PI.

J Gastroenterol Hepatol. 2012 Apr;27(4):654-61. doi: 10.1111/j.1440-1746.2012.07085.x.

PMID:
22283743
13.

Risk factors for gastrointestinal bleeding associated with low-dose aspirin.

Valkhoff VE, Sturkenboom MC, Kuipers EJ.

Best Pract Res Clin Gastroenterol. 2012 Apr;26(2):125-40. doi: 10.1016/j.bpg.2012.01.011. Review.

PMID:
22542151
14.

Continuation of low-dose aspirin therapy in peptic ulcer bleeding: a randomized trial.

Sung JJ, Lau JY, Ching JY, Wu JC, Lee YT, Chiu PW, Leung VK, Wong VW, Chan FK.

Ann Intern Med. 2010 Jan 5;152(1):1-9. doi: 10.7326/0003-4819-152-1-201001050-00179. Epub 2009 Nov 30.

PMID:
19949136
15.

[Does dual antiplatelet therapy always require gastroprotection? Gastroprotection with proton pump inhibitors is advisable for all patients who need dual antiplatelet therapy].

Morini S, Zullo A.

G Ital Cardiol (Rome). 2010 Jun;11(6):488-92; discussion 492. Italian. No abstract available.

PMID:
20922875
16.

[Antiplatelet agents and proton pump inhibitors. How can the risk-benefit balance be optimized in patients at risk for cardiovascular disease and gastrointestinal bleeding?].

Casado-Arroyo R, Muñoz-Villalenguas M, Lanas Arbeloa A.

Gastroenterol Hepatol. 2011 Aug-Sep;34(7):478-91. doi: 10.1016/j.gastrohep.2011.04.002. Epub 2011 Jun 17. Review. Spanish.

PMID:
21684042
17.

Is NSAIDs-related gastrointestinal damage preventable?

Gargallo CJ, Lanas A.

J Dig Dis. 2013 Feb;14(2):55-61. doi: 10.1111/1751-2980.12019.

PMID:
23216831
18.

Current approaches to reducing gastrointestinal toxicity of low-dose aspirin.

Lanas AI.

Am J Med. 2001 Jan 8;110(1A):70S-73S.

PMID:
11166003
19.

Summaries for patients. Benefits and risks of continuing aspirin in patients with peptic ulcer bleeding.

[No authors listed]

Ann Intern Med. 2010 Jan 5;152(1):I-20. doi: 10.7326/0003-4819-152-1-201001050-00178. Epub 2009 Nov 30. No abstract available.

PMID:
19949137
20.

Aspirin and proton pump inhibitor combination therapy for prevention of cardiovascular disease and Barrett's esophagus.

Peura DA, Wilcox CM.

Postgrad Med. 2014 Jan;126(1):87-96. doi: 10.3810/pgm.2014.01.2728. Review.

PMID:
24393755

Supplemental Content

Support Center